Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study shows AI can predict language success after cochlear implants

30

Dec 2025

Study shows AI can predict language success after cochlear implants

AI model using deep transfer learning – the most advanced form of machine learning – predicted with 92 % accuracy spoken language outcomes at one-to-three years after cochlear implants (implanted electronic hearing device), according to a large international study published in JAMA Otolaryngology-Head & Neck Surgery.

Rising gestational diabetes rates raise alarms for maternal and child health

30

Dec 2025

Rising gestational diabetes rates raise alarms for maternal and child health

Gestational diabetes rose every single year in the U.S. from 2016 through 2024, according to a new Northwestern Medicine analysis of more than 12 million U.S. births. The condition, which raises health risks for both mother and baby, shot up 36 % over the nine-year period (from 58 to 79 cases per 1,000 births) and increased across every racial and ethnic group.

Reduced peanut OIT dose offers safer, accessible treatment for children

30

Dec 2025

Reduced peanut OIT dose offers safer, accessible treatment for children

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection to peanut, finds a new study led by The Hospital for Sick Children (SickKids) and Montreal Children's Hospital. Researchers found that a small dose can help children with their peanut allergy and reduce the risk of severe reactions from accidental exposures, with less side effects than the current standard treatment.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.